Table 1.

Patients’ characteristics

Patient	Age	Sex	Ethnicity	Medical history	HCV-RNA/HBV-DNA (UI/mL)	Risk factor for chronic hepatitis	Clinical follow-up/therapy
HCV-Ab positive
Patient 1	67	F	Caucasian	Ex smoker, previous appendicectomy	HCV-RNA 7.4 × 106	Age*	Lost to follow up
Patient 2	60	M	Caucasian	Heart failure, atrial fibrillation, T2DM	HCV-RNA 6.4 × 105	Age*	HCV positive serology since 2015, unknown to patient. Scheduled ambulatorial follow-up, death for other cause before data of visit
Patient 3	71	M	Caucasian	Epilepsy, poliomyelitis, post-traumatic cerebral bleeding	Not done	Age*	Death the day after serology performed
Patient 4	103	F	Caucasian	T2DM, psoriasis	Not done	Age*	HCV positive serology since 2015, unknown to patient
Patient 5	85	F	Caucasian	Myocardial ischemia, CKD	Not done	Age*	Death 4 days after serology performed
Patient 6	54	M	Caucasian	Asthma, ex-IDU	Negative	IDU	None required
Patient 7	86	M	Caucasian	Atrial fibrillation, COPD, CKD	Negative	Age*	None required
Patient 8	80	F	Caucasian	COPD, T2DM, obesity	Not done	Age*	Death during a second hospitalization in June 2021
Patient 9	84	M	Caucasian	Atrial fibrillation, heart failure, T2DM	Not done	Age*	Death during hospitalization
Patient 10	82	M	Caucasian	COPD, T2DM, alcohol abuse	Negative	Age*	HCV positive serology since 2014, unknown to patient
Patient 11	21	F	Caucasian	IDU, bipolar disorder	Not done	IDU	Lost to follow up
HBsAg positive
Patient 1	60	M	Caucasian	Hypertension, Elher-Danlos syndrome and mitral prolapse, spinocellular carcinoma with lymph nodal metastasis	Not done	Age*	Death during hospitalization
Patient 2	49	M	Caucasian	Psoriasis	Negative	Unknown	None

Ab antibody, Ag antigen, CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, DAA direct acting antivirals, F female, IDU intravenous drug users, M male, T2DM type 2 diabetes mellitus

*Age: people born between 1945 and 1965 or with possible exposure to transfusion or injection with glass syringes between 50s’ and 80s’